drugset

drugset / Trial / NCT04278937

Antenatal Azithromycin to Prevent Preterm Birth in Pregnant Women With Vaginal Cerclage

NCT04278937 ↗

Phase 4 Completed 50 enrolled Ain Shams Maternity Hospital

RandomizedParallel-groupOpen-labelPrevention

Summary

In women with indicated vaginal cerclage, this study aims to assess the efficacy of antenatal prophylactic Azithromycin in preventing preterm labor.

Timeline

Start: 2019-04-15
Primary completion: 2020-02-15
Completion: 2020-04-15

Publications

Ahmed RHM, Bayoumy HA, Ashoush SA, Gabr WKL. Antenatal azithromycin to prevent preterm birth in pregnant women with vaginal cerclage: A randomized clinical trial. Turk J Obstet Gynecol. 2023 Mar 10;20(1):1-7. doi: 10.4274/tjod.galenos.2023.47715.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Azithromycin	Small molecule	500 mg	Oral

Indications

No indication recorded.